drugset
drugset / Trial / NCT03172234

Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation

NCT03172234 ↗

Phase 2/3 Completed 90 enrolled Ghada Mohammed AboelFadl
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To evaluate the effect of oral amantadine versus gabapentin premedication on the hemodynamic response to laryngoscopy and tracheal intubation and their effect on β-endorphins.

Timeline

Start
2017-06-15
Primary completion
2018-05-15
Completion
2018-05-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 800 mg Oral

Indications

No indication recorded.